CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Novartis to acquire Myricx Bio in up to $1.5bn deal

Positive
AI Analysis

Summary

Novartis has agreed to acquire UK-based biotechnology company Myricx Bio in a transaction valued at up to $1.5 billion.

Importance:7/10
Sentiment:
0.50
M&AacquisitionbiotechUK
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 6, 2026 10:08 AM

Read Original